Literature DB >> 32387476

Mechanisms of HBV immune evasion.

Adrian Kuipery1, Adam J Gehring2, Masanori Isogawa3.   

Abstract

The concept of immune evasion is a longstanding topic of debate during chronic Hepatitis B Virus infection. The 292 million individuals chronically infected by HBV are clear evidence that the virus avoids elimination by the immune system. The exact mechanisms of immune evasion remain undefined and are distinct, but likely interconnected, between innate and adaptive immunity. There is a significant body of evidence that supports peripheral tolerance and exhaustion of adaptive immunity but our understanding of the role that central tolerance plays is still developing. Innate immunity instructs the adaptive immune response and subversion of its functionality will impact both T and B cell responses. However, literature around the interaction of HBV with innate immunity is inconsistent, with reports suggesting that HBV avoids innate recognition, suppresses innate recognition, or activates innate immunity. This complexity has led to confusion and controversy. This review will discuss the mechanisms of central and peripheral tolerance/exhaustion of adaptive immunity in the context of chronic HBV infection. We also cover the interaction of HBV with cells of the innate immune system and propose concepts for the heterogeneity of responses in chronically infected patients.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adaptive immunity; Exhaustion; Hepatitis B virus (HBV); Immunosuppression; Innate immunity; Tolerance

Mesh:

Year:  2020        PMID: 32387476     DOI: 10.1016/j.antiviral.2020.104816

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  13 in total

Review 1.  New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells.

Authors:  Yanni Liu; Paul Nicklin; Yuan He
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

Review 2.  A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook.

Authors:  Anna Kramvis; Kyong-Mi Chang; Maura Dandri; Patrizia Farci; Dieter Glebe; Jianming Hu; Harry L A Janssen; Daryl T Y Lau; Capucine Penicaud; Teresa Pollicino; Barbara Testoni; Florian Van Bömmel; Ourania Andrisani; Maria Beumont-Mauviel; Timothy M Block; Henry L Y Chan; Gavin A Cloherty; William E Delaney; Anna Maria Geretti; Adam Gehring; Kathy Jackson; Oliver Lenz; Mala K Maini; Veronica Miller; Ulrike Protzer; Jenny C Yang; Man-Fung Yuen; Fabien Zoulim; Peter A Revill
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-07-20       Impact factor: 73.082

Review 3.  Immunobiology and pathogenesis of hepatitis B virus infection.

Authors:  Matteo Iannacone; Luca G Guidotti
Journal:  Nat Rev Immunol       Date:  2021-05-17       Impact factor: 53.106

4.  A Simple and Rapid Method for Quantitative Detection of Hepatitis B Virus Drug-resistant Mutations.

Authors:  Ran Wang; Zhengde Xie
Journal:  J Clin Transl Hepatol       Date:  2021-04-16

Review 5.  Regulation of Pattern-Recognition Receptor Signaling by HBX During Hepatitis B Virus Infection.

Authors:  Hongjuan You; Suping Qin; Fulong Zhang; Wei Hu; Xiaocui Li; Dongsheng Liu; Fanyun Kong; Xiucheng Pan; Kuiyang Zheng; Renxian Tang
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

Review 6.  Interaction between the Hepatitis B Virus and Cellular FLIP Variants in Viral Replication and the Innate Immune System.

Authors:  Ah Ram Lee; Yong Kwang Park; Mehrangiz Dezhbord; Kyun-Hwan Kim
Journal:  Viruses       Date:  2022-02-11       Impact factor: 5.048

Review 7.  Recent Advances in Hepatitis B Treatment.

Authors:  Georgia-Myrto Prifti; Dimitrios Moianos; Erofili Giannakopoulou; Vasiliki Pardali; John E Tavis; Grigoris Zoidis
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-01

Review 8.  Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment.

Authors:  Georgios Axiaris; Evanthia Zampeli; Spyridon Michopoulos; Giorgos Bamias
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

Review 9.  RNA Interference Therapy for Chronic Hepatitis B Predicts the Importance of Addressing Viral Integration When Developing Novel Cure Strategies.

Authors:  Christine I Wooddell; Adam J Gehring; Man-Fung Yuen; Bruce D Given
Journal:  Viruses       Date:  2021-03-30       Impact factor: 5.048

10.  Identification and Mapping of HBsAg Loss-Related B-Cell Linear Epitopes in Chronic HBV Patients by Peptide Array.

Authors:  Shuqin Gu; Zhipeng Liu; Li Lin; Shihong Zhong; Yanchen Ma; Xiaoyi Li; Guofu Ye; Chunhua Wen; Yongyin Li; Libo Tang
Journal:  Front Immunol       Date:  2021-10-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.